设为首页 电子邮箱 联系我们

本刊最新招聘信息请见“通知公告”!  本刊投稿系统试运行中,欢迎投稿!如投稿有问题,可直接将稿件发送至zgyy8888@163.com

 

主管单位:中华人民共和国   

国家卫生健康委员会

主办单位:中国医师协会
总编辑:
杨秋

编辑部主任:吴翔宇

邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)

                  

过刊目录

2020 年第 1 期 第 15 卷

硝苯地平缓释片联合硫酸镁对妊娠期高血压患者肾功能及心脏血流动力学的影响

Effect of nifedipine sustained-release tablets combined with magnesium sulfate on renal function and cardiac hemodynamics in patients with pregnancy-induced hypertension

作者:任保红1付玉峰1孟庆勇1赵燕2陈小琳2

英文作者:

单位:1陕西省汉中市中心医院药剂科723000;2西安交通大学附属西安市中心医院肾病科710003

英文单位:

关键词:妊娠期高血压;硝苯地平缓释片;硫酸镁注射液;肾功能;心脏血流动力学

英文关键词:

  • 摘要:
  • 【摘要】目的    探讨硝苯地平缓释片联合硫酸镁对妊娠期高血压患者肾功能及心脏血流动力学的影响。方法    选择2017年3月至2019年3月陕西省汉中市中心医院收治的妊娠期高血压患者110例,采用随机数余数分组法分为联合组和单药组,各55例。单药组采用硫酸镁注射液治疗,联合组在单药组基础上联合硝苯地平缓释片治疗。比较2组治疗前后24 h尿肌酐量及尿蛋白量、阻力指数、脐动脉舒张压血流峰速比值(S/D)、血浆黏度、血细胞比容、收缩压、舒张压、同型半胱氨酸(Hcy)和C反应蛋白(CRP)水平。结果    治疗后,2组24 h尿肌酐量、24 h尿蛋白量、阻力指数、S/D、血浆黏度、血细胞比容、收缩压、舒张压和血清Hcy、CRP水平均明显低于治疗前,且联合组明显低于单药组[(7.0±1.6)mmol比(9.0±1.9)mmol、(1.02±0.22)g比(1.96±0.25)g、(0.24±0.05)比(0.43±0.06)、(1.6±0.3)比(2.0±0.4)、(2.1±0.4)mPa·s比(3.2±0.4)mPa·s、(35.7±2.6)%比(39.3±2.3)%、(112±7)mmHg(1 mmHg=0.133 kPa)比(129±7)mmHg、(84±6)mmHg比(95±6)mmHg、(10.5±1.6)μmol/L比(14.7±2.0)μmol/L、(1.5±0.4)mg/L比(2.0±0.5)mg/L],差异均有统计学意义(均P<0.05)。结论    硝苯地平缓释片联合硫酸镁能有效改善妊娠期高血压患者肾功能及心脏血流动力学,使血压恢复至正常范围。

  • 【Abstract】Objective    To investigate the effect of nifedipine sustained-release tablets combined with magnesium sulfate on renal function and cardiac hemodynamics in patients with pregnancy-induced hypertension. Methods    A total of 110 cases of pregnancy-induced hypertension admitted to Hanzhong Central Hospital, Shaanxi Province were enrolled from March 2017 to March 2019. The patients were randomly divided into combination group and single drug group, with 55 cases in each group. The single drug group was treated with magnesium sulfate injection and the combination group was treated with nifedipine sustained-release tablets plus magnesium sulfate. Relevant indexes including 24 h urine creatinine and urinary protein, resistance index, umbilical artery diastolic peak velocity ratio(S/D), plasma viscosity, hematocrit, systolic blood pressure, diastolic blood pressure, serum homocysteine(Hcy) and C-reactive protein(CRP) were analyzed before and after treatment. Results    After treatment, 24 h urinary creatinine, 24 h urinary protein, resistance index, S/D, plasma viscosity, hematocrit, systolic blood pressure, diastolic blood pressure, serum Hcy and CRP levels significantly reduced in both groups; the indexes in the combionation group were significantly lower than those in the single drug group[(7.0±1.6)mmol vs (9.0±1.9)mmol, (1.02±0.22)g vs (1.96±0.25)g, (0.24±0.05) vs (0.43±0.06), (1.6±0.3) vs (2.0±0.4), (2.1±0.4)mPa·s vs (3.2±0.4)mPa·s, (35.7±2.6)% vs (39.3±2.3)%, (112±7)mmHg vs (129±7)mmHg, (84±6)mmHg vs (95±6)mmHg, (10.5±1.6)μmol/L vs (14.7±2.0)μmol/L, (1.5±0.4)mg/L vs (2.0±0.5)mg/L](all P<0.05). Conclusion    Nifedipine sustained-release tablets combined with magnesium sulfate can effectively improve renal function, cardiac hemodynamics and blood pressure in patients with pregnancy-induced hypertension.

copyright 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址:www.chinamedicinej.com 京ICP备2020043099号-3

当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。







安卓


苹果

关闭